SILO

Silo Pharma Inc

SILO.US silopharma.com + Research + Basket
CIK 0001514183
Employees 3
Phone 718 400 9031
Fiscal year end December
IPO May 13, 2014
Address 677 North Washington Boulevard, Sarasota, FL, United States, 34236
1.29
-0.04 (-3.01%)
USD · NASDAQ
52-week range
1.10
10.43
Trading at 2% of the 52-week range
Market Cap
2.93M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
4.33
Div. Yield
N/A
% Institutions
5.80%
% Insiders
8.17%

1 Year

-83.0%

3 Year

-94.6%

10 Year

+416.0%
Description

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Actions

Add an action for SILO.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Eric Weisblum Chairman, President & CEO 1970
Mr. Daniel E. Ryweck Chief Financial Officer 1965

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 04, 2024 Eric Weisblum N/A Purchase 600.00 $1.96 $1.18K SEC
Apr 01, 2024 Eric Weisblum N/A Purchase 1.10K $1.91 $2.10K SEC
Mar 28, 2024 Eric Weisblum N/A Purchase 3.41K $1.94 $6.61K SEC
Dec 19, 2023 Eric Weisblum N/A Purchase 500.00 $1.63 $815.00 SEC
Dec 14, 2023 Eric Weisblum N/A Purchase 200.00 $1.50 $300.00 SEC
Dec 07, 2023 Eric Weisblum N/A Purchase 324.00 $1.36 $440.64 SEC
Dec 05, 2023 Eric Weisblum N/A Purchase 600.00 $1.39 $834.00 SEC
Nov 30, 2023 Eric Weisblum N/A Purchase 1.00K $1.53 $1.53K SEC
Nov 27, 2023 Eric Weisblum N/A Purchase 250.00 $1.78 $445.00 SEC
Nov 22, 2023 Eric Weisblum N/A Purchase 400.00 $1.68 $672.00 SEC
Nov 16, 2023 Eric Weisblum N/A Purchase 1.10K $1.33 $1.46K SEC
May 26, 2023 Daniel E Ryweck N/A Purchase 1.00K $2.13 $2.13K SEC
May 17, 2023 Eric Weisblum N/A Purchase 2.50K $2.06 $5.15K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
AdvisorShares Investments, LLC 75.58K Jun 30, 2026 3.68% $0.06 70.74%
Citadel Advisors Llc 16.80K Jun 30, 2026 0.82% $0.00 1,074.83%
Vanguard Capital Management, LLC 11.96K Jun 30, 2026 0.58% $0.00 1,498.40%
Vanguard Fiduciary Trust Co 874.00 Jun 30, 2026 0.04% $0.00 0.11%
Tower Research Capital LLC 181.00 Jun 30, 2026 0.01% $0.00 61.61%
IFP Advisors, LLC 175.00 Jun 30, 2026 0.01% $0.00 1,358.33%
HARBOUR INVESTMENTS, INC. 14.00 Jun 30, 2026 0.00% $0.00 0.00%
Citigroup Inc 1.00 Jun 30, 2026 0.00% $0.00 0.00%
State Street Corp 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Susquehanna International Group, LLP 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Jane Street Group LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Wells Fargo & Co 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Geode Capital Management, LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
LPL Financial Corp 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
XTX Topco Ltd 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
TWO SIGMA SECURITIES, LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 AdvisorShares Psychedelics ETF 96.11K 4.36% ▲ 0.00% Oct 30, 2026
2 Fidelity Extended Market Index 8.57K 0.39% ▲ 44.49% Aug 31, 2026
3 Fidelity Series Total Market Index 2.18K 0.10% ▲ 0.00% Aug 31, 2026
4 Fidelity Total Market Index 260.00 0.01% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $2.93M
EBITDA: $-4.45M
Book Value: $4.33
Earnings/Share: $-4.26
Profit Margin: 0.00%
Operating Margin: -8,250.46%
ROA (TTM): -44.25%
ROE (TTM): -91.23%
Revenue (TTM): $54.08K
Revenue/Share (TTM): $0.06
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $-2.61M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 2.20M
Shares Float: 1.57M
% Insiders: 8.17%
% Institutions: 5.80%
Shares Short: 22.08K
Shares Short (Prior Month): 34.87K
Short Ratio: 0.19
Short % Float: 1.08%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$72.10K
Cost of Goods Sold
adjust
$-886.06K
Gross Profit
subtotal
$-813.96K
SG&A
adjust
$-2.15M
R&D
adjust
$-2.16M
Operating Income
subtotal
$-4.28M
Other / Non-Operating Items
adjust
$52.96K
Net Income
subtotal
$-4.23M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SILO.US!